Abstract:Development of small-sized nanoformulations for effective tumor penetration, particularly for those tumors with dense stroma is a major challenge in cancer nanomedicine. It is even more challenging to achieve effective co-loading of both hydrophobic and hydrophilic anticancer agents through a small-sized nanocarrier. In this work, we designed a novel redox-responsive gemcitabine (GEM)-conjugated polymer POEG-co-PVDGEM (PGEM) as a small-sized nanocarrier to co-deliver hydrophilic GEM and hydrophobic paclitaxel (PTX). Methods: The in vitro physicochemical and biological properties of PTX/PGEM NPs were characterized. The efficiency of the PGEM carrier in selective codelivery of GEM and PTX in two murine tumor models as well as a patient derived xenograft model (PDX) was also evaluated. In addition, we investigated the changes in tumor immune microenvironment after treatment with PTX/PGEM nanoparticles. Results: We discovered that GEM conjugation could significantly decrease the nanoparticle size from 160 nm to 13 nm. Moreover, different from most reported GEM-conjugated polymers, PGEM polymer could serve as a prodrug carrier to load a wide variety of hydrophobic agents with high drug loading capacity and excellent stability. More importantly, our strategy could be extended to various nucleotides-based drugs such as azacytidine, decitabine and cytarabine, suggesting a new platform for co-delivery of various first line hydrophilic and hydrophobic anticancer agents. Imaging showed that our small-sized carrier was much more effective in tumor accumulation and penetration compared to the relatively large-sized drug carrier. The PGEM prodrug-based carrier not only well retained the pharmacological activity of GEM, but also boosted T-cell immune response. Furthermore, delivery of PTX via PGEM led to significantly improved antitumor activity in several murine cancer models and a PDX model of colon cancer. Conclusion: This work not only provided a small-sized carrier platform that was able to load multiple hydrophilic and hydrophobic drugs with high loading capacity, but also provided an effective regimen for enhanced tumor penetration and improved anti-tumor immunity.

Size-dependent translocation and lymphatic transportation of polymeric nanocarriers post intraperitoneal administration

Pharmacokinetics and Biodistribution of Near-Infrared Fluorescence Polymeric Nanoparticles

Impact of Semiconducting Perylene Diimide Nanoparticle Size on Lymph Node Mapping and Cancer Imaging

Size-Dependent Regulation of Intracellular Trafficking of Polystyrene Nanoparticle-Based Drug-Delivery Systems

Liposomally Formulated Phospholipid-Conjugated Novel Near-Infrared Fluorescence Probe for Particle Size Effect on Cellular Uptake and Biodistribution in Vivo.

Three-Dimensional Lymphatics-on-a-Chip Reveals Distinct, Size-Dependent Nanoparticle Transport Mechanisms in Lymphatic Drug Delivery

Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers.

In vivo biodistribution of mixed shell micelles with tunable hydrophilic/hydrophobic surface.

Effective treatment of the primary tumor and lymph node metastasis by polymeric micelles with variable particle sizes

Bioimaging of Intact Polycaprolactone Nanoparticles Using Aggregation-Caused Quenching Probes: Size-Dependent Translocation Via Oral Delivery

The Passive Targeting of Polymeric Micelles in Various Types and Sizes of Tumor Models

The journey of nanoparticles in the abdominal cavity: Exploring their in vivo fate and impact factors

A NIR light triggered disintegratable nanoplatform for enhanced penetration and chemotherapy in deep tumor tissues

Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies

Polymeric Micelles for Enhanced Lymphatic Drug Delivery to Treat Metastatic Tumors.

A Novel Size-Tunable Nanocarrier System for Targeted Anticancer Drug Delivery

Ph-Responsive Size-Shrinkable Mesoporous Silica-Based Nanocarriers for Improving Tumor Penetration and Therapeutic Efficacy.

A Novel Strategy Through Combining Irgd Peptide with Tumor-Microenvironment-Responsive and Multistage Nanoparticles for Deep Tumor Penetration.

High Loading of Hydrophobic and Hydrophilic Agents Via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy

Synthesis And Characterization Of Multifunctional Hybrid-Polymeric Nanoparticles For Drug Delivery And Multimodal Imaging Of Cancer

Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics